Author
Listed:
- Ryohichi Sugimura
(Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Boston Children’s Hospital and Dana-Farber Cancer Institute
Harvard Medical School
Harvard Stem Cell Institute
Manton Center for Orphan Disease Research)
- Deepak Kumar Jha
(Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Boston Children’s Hospital and Dana-Farber Cancer Institute
Harvard Medical School
Harvard Stem Cell Institute
Manton Center for Orphan Disease Research)
- Areum Han
(Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Boston Children’s Hospital and Dana-Farber Cancer Institute
Harvard Medical School)
- Clara Soria-Valles
(Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Boston Children’s Hospital and Dana-Farber Cancer Institute
Harvard Medical School
Harvard Stem Cell Institute
Manton Center for Orphan Disease Research)
- Edroaldo Lummertz da Rocha
(Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Boston Children’s Hospital and Dana-Farber Cancer Institute
Harvard Medical School
Harvard Stem Cell Institute
Manton Center for Orphan Disease Research)
- Yi-Fen Lu
(Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Boston Children’s Hospital and Dana-Farber Cancer Institute
Harvard Medical School
Harvard Stem Cell Institute
Manton Center for Orphan Disease Research)
- Jeremy A. Goettel
(Hepatology and Nutrition, Boston Children’s Hospital
Harvard Medical School)
- Erik Serrao
(Harvard Medical School)
- R. Grant Rowe
(Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Boston Children’s Hospital and Dana-Farber Cancer Institute)
- Mohan Malleshaiah
(Harvard Medical School)
- Irene Wong
(Brandeis University)
- Patricia Sousa
(Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Boston Children’s Hospital and Dana-Farber Cancer Institute
Harvard Medical School
Harvard Stem Cell Institute
Manton Center for Orphan Disease Research)
- Ted N. Zhu
(Program in Computer Science, Harvard University)
- Andrea Ditadi
(McEwen Centre for Regenerative Medicine, University Health Network)
- Gordon Keller
(McEwen Centre for Regenerative Medicine, University Health Network)
- Alan N. Engelman
(Harvard Medical School)
- Scott B. Snapper
(Hepatology and Nutrition, Boston Children’s Hospital
Harvard Medical School
Brigham and Women’s Hospital)
- Sergei Doulatov
(Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Boston Children’s Hospital and Dana-Farber Cancer Institute
Harvard Medical School
Harvard Stem Cell Institute
Manton Center for Orphan Disease Research)
- George Q. Daley
(Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Boston Children’s Hospital and Dana-Farber Cancer Institute
Harvard Medical School
Harvard Stem Cell Institute
Manton Center for Orphan Disease Research)
Abstract
A variety of tissue lineages can be differentiated from pluripotent stem cells by mimicking embryonic development through stepwise exposure to morphogens, or by conversion of one differentiated cell type into another by enforced expression of master transcription factors. Here, to yield functional human haematopoietic stem cells, we perform morphogen-directed differentiation of human pluripotent stem cells into haemogenic endothelium followed by screening of 26 candidate haematopoietic stem-cell-specifying transcription factors for their capacity to promote multi-lineage haematopoietic engraftment in mouse hosts. We recover seven transcription factors (ERG, HOXA5, HOXA9, HOXA10, LCOR, RUNX1 and SPI1) that are sufficient to convert haemogenic endothelium into haematopoietic stem and progenitor cells that engraft myeloid, B and T cells in primary and secondary mouse recipients. Our combined approach of morphogen-driven differentiation and transcription-factor-mediated cell fate conversion produces haematopoietic stem and progenitor cells from pluripotent stem cells and holds promise for modelling haematopoietic disease in humanized mice and for therapeutic strategies in genetic blood disorders.
Suggested Citation
Ryohichi Sugimura & Deepak Kumar Jha & Areum Han & Clara Soria-Valles & Edroaldo Lummertz da Rocha & Yi-Fen Lu & Jeremy A. Goettel & Erik Serrao & R. Grant Rowe & Mohan Malleshaiah & Irene Wong & Patr, 2017.
"Haematopoietic stem and progenitor cells from human pluripotent stem cells,"
Nature, Nature, vol. 545(7655), pages 432-438, May.
Handle:
RePEc:nat:nature:v:545:y:2017:i:7655:d:10.1038_nature22370
DOI: 10.1038/nature22370
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Yinghui Li & Mei He & Wenshan Zhang & Wei Liu & Hui Xu & Ming Yang & Hexiao Zhang & Haiwei Liang & Wenjing Li & Zhaozhao Wu & Weichao Fu & Shiqi Xu & Xiaolei Liu & Sibin Fan & Liwei Zhou & Chaoqun Wan, 2023.
"Expansion of human megakaryocyte-biased hematopoietic stem cells by biomimetic Microniche,"
Nature Communications, Nature, vol. 14(1), pages 1-16, December.
- Pierre Sabatier & Christian M. Beusch & Amir A. Saei & Mike Aoun & Noah Moruzzi & Ana Coelho & Niels Leijten & Magnus Nordenskjöld & Patrick Micke & Diana Maltseva & Alexander G. Tonevitsky & Vincent , 2021.
"An integrative proteomics method identifies a regulator of translation during stem cell maintenance and differentiation,"
Nature Communications, Nature, vol. 12(1), pages 1-16, December.
- Patrick Coulombe & Grace Cole & Amanda Fentiman & Jeremy D. K. Parker & Eric Yung & Misha Bilenky & Lemlem Degefie & Patrick Lac & Maggie Y. M. Ling & Derek Tam & R. Keith Humphries & Aly Karsan, 2023.
"Meis1 establishes the pre-hemogenic endothelial state prior to Runx1 expression,"
Nature Communications, Nature, vol. 14(1), pages 1-15, December.
- Pragya Gupta & Sangam Giri Goswami & Geeta Kumari & Vinodh Saravanakumar & Nupur Bhargava & Akhila Balakrishna Rai & Praveen Singh & Rahul C. Bhoyar & V. R. Arvinden & Padma Gunda & Suman Jain & Vanya, 2024.
"Development of pathophysiologically relevant models of sickle cell disease and β-thalassemia for therapeutic studies,"
Nature Communications, Nature, vol. 15(1), pages 1-18, December.
- Shuyang Cai & Honghu Li & Ruxiu Tie & Wei Shan & Qian Luo & Shufen Wang & Cong Feng & Huiqiao Chen & Meng Zhang & Yulin Xu & Xia Li & Ming Chen & Jiahui Lu & Pengxu Qian & He Huang, 2024.
"Nlrc3 signaling is indispensable for hematopoietic stem cell emergence via Notch signaling in vertebrates,"
Nature Communications, Nature, vol. 15(1), pages 1-16, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:545:y:2017:i:7655:d:10.1038_nature22370. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.